FEEDENvue Medical, Inc.

NASDAQ · Healthcare · Large Cap · Mkt cap $423.5B · Vol 31.76M

$78.90

▲ +3.01% today

Fetching live price…

🏛️ Member of:Russell 2000

God's Eye forensics

Accounting quality and solvency screens. Anything that can't be computed from available filings data is left blank rather than estimated.

Piotroski F-Score

5/5

5

5 of 5 financial-health checks passed (4 checks need data this provider doesn't publish).

Altman Z-Score

Insufficient data

—

Needs total assets, operating profit and debt — not published for this listing yet.

Beneish (earnings quality)

Insufficient data

—

The full manipulation model needs two years of receivables, depreciation and accrual data, which isn't published for this listing.

Scores are free. The criteria-by-criteria breakdown — exactly which checks this company failed — is part of DeepScreen Pro.

Fundamental breakdown — raw ratios are free · fetching live data — showing modeled estimates for now

P/E Ratio (TTM)

Modeled

24.6x

Fairly priced

Contextual insight — DeepScreen Pro

PEG Ratio

Modeled

1.44

Fairly valued

Contextual insight — DeepScreen Pro

P/S Ratio

Modeled

2.26x

Moderate

Contextual insight — DeepScreen Pro

P/B Ratio

Modeled

7.58x

Typical for the sector

Contextual insight — DeepScreen Pro

EV/Revenue

Modeled

2.91x

Low for an asset-light business

Contextual insight — DeepScreen Pro

EV/EBITDA

Modeled

15.3x

Fair

Contextual insight — DeepScreen Pro

ROE

Modeled

30.8%

Excellent shareholder returns

Contextual insight — DeepScreen Pro

ROA

Modeled

21.5%

Strong for asset-light

Contextual insight — DeepScreen Pro

ROCE

Modeled

28.9%

High-quality compounder

Contextual insight — DeepScreen Pro

Debt / Equity

Modeled

0.08x

Conservative balance sheet

Contextual insight — DeepScreen Pro

LT Debt / Equity

Modeled

0.04x

Very low structural debt

Contextual insight — DeepScreen Pro

Payout Ratio

Modeled

40%

Ideal balance — sustainable with room to reinvest

Contextual insight — DeepScreen Pro

Operating Leverage

Modeled

2.75x

Profits amplify — both ways

Contextual insight — DeepScreen Pro

Company financials

EPS (TTM): $3.21
Revenue (TTM): $187.4B
Net margin: 9.2%
EBITDA margin: 19%
Earnings growth: 17.1%
Dividend yield: 1.63%
Payout ratio: 40%
Debt / equity: 0.08x

Live data hasn't loaded yet — figures shown are DeepScreen's modeled estimates.

FEED live news

LIVE

Loading live headlines…